ATE371659T1 - Pyrazolotriazinderivate als gaba-rezeptorliganden - Google Patents

Pyrazolotriazinderivate als gaba-rezeptorliganden

Info

Publication number
ATE371659T1
ATE371659T1 AT99949224T AT99949224T ATE371659T1 AT E371659 T1 ATE371659 T1 AT E371659T1 AT 99949224 T AT99949224 T AT 99949224T AT 99949224 T AT99949224 T AT 99949224T AT E371659 T1 ATE371659 T1 AT E371659T1
Authority
AT
Austria
Prior art keywords
receptor ligands
gaba receptor
pyrazolotriazine
derivatives
pyrazolotriazine derivatives
Prior art date
Application number
AT99949224T
Other languages
English (en)
Inventor
William Robert Carling
Andrew Mitchinson
Kevin William Moore
Michael Geoffrey Neil Russell
Gayle Scott
Leslie Joseph Street
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9822716.8A external-priority patent/GB9822716D0/en
Priority claimed from GBGB9920092.5A external-priority patent/GB9920092D0/en
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE371659T1 publication Critical patent/ATE371659T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99949224T 1998-10-16 1999-10-13 Pyrazolotriazinderivate als gaba-rezeptorliganden ATE371659T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9822716.8A GB9822716D0 (en) 1998-10-16 1998-10-16 Therapeutic agents
GBGB9920092.5A GB9920092D0 (en) 1999-08-25 1999-08-25 Therapeutic agents

Publications (1)

Publication Number Publication Date
ATE371659T1 true ATE371659T1 (de) 2007-09-15

Family

ID=26314533

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99949224T ATE371659T1 (de) 1998-10-16 1999-10-13 Pyrazolotriazinderivate als gaba-rezeptorliganden

Country Status (9)

Country Link
US (1) US6476030B1 (de)
EP (1) EP1121361B1 (de)
JP (1) JP2002527519A (de)
AT (1) ATE371659T1 (de)
AU (1) AU760688B2 (de)
CA (1) CA2346289A1 (de)
DE (1) DE69936998T2 (de)
ES (1) ES2291043T3 (de)
WO (1) WO2000023449A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9919957D0 (en) * 1999-08-23 1999-10-27 Merck Sharp & Dohme Therapeutic agents
US6355638B1 (en) * 1999-11-25 2002-03-12 Merck Sharp & Dohme Ltd. Pyrazolo[1,5-d][1,2,4] triazines for enhancing cognition
GB0008696D0 (en) 2000-04-07 2000-05-31 Merck Sharp & Dohme Therapeutic agents
GB0210127D0 (en) * 2002-05-02 2002-06-12 Merck Sharp & Dohme Therapeutic agents
GB0210124D0 (en) * 2002-05-02 2002-06-12 Merck Sharp & Dohme Therapeutic agents
EP2275096A3 (de) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenese durch modulation des Muscarinrezeptors
EP2258357A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese mit Acetylcholinesterasehemmer
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP2314289A1 (de) 2005-10-31 2011-04-27 Braincells, Inc. Gaba-rezeptor-vermittelte modulation von neurogenese
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2021000A2 (de) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenese mittels angiotensin-modulation
WO2008030651A1 (en) * 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
JP5697446B2 (ja) 2007-05-22 2015-04-08 ワイス・エルエルシー ヒドラジドを製造するための改善されたプロセス
PL2280973T3 (pl) 2008-04-23 2013-05-31 Gilead Sciences Inc Analogi karba-nukleozydowe do leczenia przeciwwirusowego
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
NZ599404A (en) 2009-09-21 2014-02-28 Gilead Sciences Inc Processes and intermediates for the preparation of 1’-substituted carba-nucleoside analogs
EA025311B1 (ru) 2010-07-19 2016-12-30 Гайлид Сайэнсиз, Инк. Способы получения диастереомерно чистых фосфорамидатных пролекарств
PT2595980E (pt) 2010-07-22 2014-11-27 Gilead Sciences Inc Métodos e compostos para tratar infeções pelo vírus da família paramyxoviridae
RU2582337C2 (ru) * 2010-11-09 2016-04-27 Ф.Хоффманн-Ля Рош Аг Производные триазола в качестве лигандов рецепторов гамк
JP6106603B2 (ja) 2011-01-11 2017-04-05 スノビオン プハルマセウトイカルス インコーポレイテッド ヘテロアリール化合物及びその使用方法
US20150374705A1 (en) * 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
TWI698444B (zh) 2014-10-29 2020-07-11 美商基利科學股份有限公司 製備核糖苷的方法
DK3349758T3 (da) 2015-09-16 2022-06-13 Gilead Sciences Inc Fremgangsmåder til behandling af arenaviridae-virusinfektioner
CN107344938B (zh) * 2016-05-06 2022-05-06 上海赛默罗生物科技有限公司 吡唑-三嗪类衍生物、其制备方法、药物组合物和用途
CN110869028B (zh) 2017-03-14 2023-01-20 吉利德科学公司 治疗猫冠状病毒感染的方法
EP4219513A1 (de) 2017-05-01 2023-08-02 Gilead Sciences, Inc. Kristalline form von (s)-2-ethylbutyl 2-((s)-(((2r,3s,4r,5r)-5-(4-aminopyrrolo[2,1-f) [1,2,4)triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran2-yl)methoxy)oat
CN111093627B (zh) 2017-07-11 2024-03-08 吉利德科学公司 用于治疗病毒感染的包含rna聚合酶抑制剂和环糊精的组合物
CN112608316B (zh) * 2019-07-30 2022-10-21 厦门宝太生物科技股份有限公司 一种吡唑并三嗪类腺苷受体拮抗剂
WO2021028645A1 (en) 2019-08-09 2021-02-18 Kalvista Pharmaceuticals Limited Plasma kallikrein inhibitors
KR20220132608A (ko) 2020-01-27 2022-09-30 길리애드 사이언시즈, 인코포레이티드 SARS CoV-2 감염증을 치료하기 위한 방법
TWI785528B (zh) 2020-03-12 2022-12-01 美商基利科學股份有限公司 1’-氰基核苷之製備方法
JP7482250B2 (ja) 2020-04-06 2024-05-13 ギリアード サイエンシーズ, インコーポレイテッド 1’-シアノ置換カルバヌクレオシド類似体の吸入製剤
EP4157272B1 (de) 2020-05-29 2025-07-02 Gilead Sciences, Inc. Remdesivir zur behandlung von viralen infektionen
IL299202A (en) 2020-06-24 2023-02-01 Gilead Sciences Inc 1'-cyano nucleoside analogs and uses thereof
US11926645B2 (en) 2020-08-27 2024-03-12 Gilead Sciences, Inc. Compounds and methods for treatment of viral infections
CN117279917A (zh) * 2021-05-21 2023-12-22 成都百裕制药股份有限公司 哌嗪衍生物及其在医药上的应用
KR20240154647A (ko) 2022-03-02 2024-10-25 길리애드 사이언시즈, 인코포레이티드 바이러스성 감염 치료를 위한 화합물 및 방법
EP4547665A1 (de) 2022-06-30 2025-05-07 Gilead Sciences, Inc. Feste formen eines nukleosidanalogons und verwendungen davon
US12357577B1 (en) 2024-02-02 2025-07-15 Gilead Sciences, Inc. Pharmaceutical formulations and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321162D0 (en) * 1993-10-13 1993-12-01 Boots Co Plc Therapeutic agents
EP0915875B1 (de) * 1996-07-25 2003-04-09 MERCK SHARP & DOHME LTD. Substituierte Triazolo-Pyridazin-Derivate als Liganden von GABA-Rezeptoren
EP0915877A1 (de) * 1996-07-25 1999-05-19 MERCK SHARP & DOHME LTD. Substituierte triazolo-pyridazinderivate als inverse agonisten des gaba-a alpha-5 rezeptor subtyps
GB9713707D0 (en) * 1997-06-27 1997-09-03 Merck Sharp & Dohme Therapeutic agents
AU746866B2 (en) * 1998-01-14 2002-05-02 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for GABA receptors

Also Published As

Publication number Publication date
WO2000023449A1 (en) 2000-04-27
AU760688B2 (en) 2003-05-22
EP1121361B1 (de) 2007-08-29
AU6219999A (en) 2000-05-08
ES2291043T3 (es) 2008-02-16
EP1121361A1 (de) 2001-08-08
CA2346289A1 (en) 2000-04-27
US6476030B1 (en) 2002-11-05
DE69936998T2 (de) 2008-05-21
JP2002527519A (ja) 2002-08-27
DE69936998D1 (de) 2007-10-11

Similar Documents

Publication Publication Date Title
DE69936998D1 (de) Pyrazolotriazinderivate als gaba-rezeptorliganden
DE60012044D1 (de) Imidazopyridinderivate als liganden für gaba-rezeptoren
DE60006835D1 (de) Imidazopyridinderivate als gaba rezeptor liganden
MA27119A1 (fr) Modulateurs tetrahydropyranyle cyclopentyle tetrahydropyrido pyridine de l'activite d'un recepteur de chimiokine
PT841929E (pt) Quinolonas e sua utilizacao terapeutica
ES2195943T3 (es) Compuestos heteroaromaticos biciclicos y triciclicos.
DK0915866T3 (da) Forbedret fremgangsmåde til syntese af beskyttende estere af (S)-3,4-dihydroxysmørsyre
GB0212048D0 (en) Therapeutic agents
TR199900047T2 (xx) Gaba resept�rleri ligandlar� olarak ikame triazolo-piridazin t�revleri
ES2175615T3 (es) Derivados de azaindol etilamina como agentes de union al receptor nicotinico de acetilcolina.
EP1501507A4 (de) Tetrahydropyranyl-cyclopentyl-tetrahydropyridopyridin-modulatoren der chemokin-rezeptor-aktivität
ATE323678T1 (de) Tri-aryl-säurederivate als ppar rezeptor liganden
DE60207416D1 (de) Imidazotriazin-derivate als gaba-rezeptor-liganden
DE60115282D1 (de) Imidazotriazin-derivate als liganden für gaba-rezeptoren
NO975663L (no) Semikarbazoner med CNS aktivitet og farmasöytiske preparater inneholdende de samme
EE200300455A (et) Imidasopürimidiini derivaadid, nende valmistamisprotsess ja kasutamine ning farmatseutiline kompositsioon
DE69617700D1 (de) Neue kondensierten isochinoline als dopamin-rezeptor-liganden
DE60235365D1 (de) Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
AP9801410A0 (en) Indoline derivatives useful as 5-HT-2C receptor antagonists.
YU59100A (sh) Postupak za dobijanje pirazolo (4,3-d) pirimidin-7-ona-3-piridilsulfonil jedinjenja i njihova intermedijera
YU22797A (sh) Postupak i intermedijarna jedinjenja za dobijanje pesticidnih fluoroolefinskih jedinjenja
DE69703115D1 (de) Zwischenprodukte um 2-imidazolin-5onederivate herzustellen.
DE69906243T2 (de) 2-Indanmethanolderivate und ihre Verwendung als Riechstoffe
DE60002292D1 (de) (3,4-dihydro-2h-benzo[1,4]oxazinyl-methyl)-3-(1h-indol-3-yl)-alkylamine
GB0428137D0 (en) Novel herbicides

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties